Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
53,512,273
-
Total 13F shares
-
32,489,801
-
Share change
-
+771,275
-
Total reported value
-
$256,715,238
-
Price per share
-
$7.90
-
Number of holders
-
67
-
Value change
-
+$5,759,402
-
Number of buys
-
25
-
Number of sells
-
30
Institutional Holders of Zenas BioPharma, Inc. - COMMON STOCK (ZBIO) as of Q1 2025
As of 31 Mar 2025,
Zenas BioPharma, Inc. - COMMON STOCK (ZBIO) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,489,801 shares.
The largest 10 holders included
SR One Capital Management, LP, ENAVATE SCIENCES GP, LLC, FMR LLC, NEA Management Company, LLC, Novo Holdings A/S, Fairmount Funds Management LLC, NVP ASSOCIATES, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vivo Capital, LLC, and FEDERATED HERMES, INC..
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.